Prof. Dr. med. Patrick Most
Sektionsleiter
(Sektion Molekulare und Translationale Kardiologie)
Arbeitsgruppenleiter
(Sektion Molekulare und translationale Kardiologie)
Head, Molecular and Translational Cardiology Division
W3-Professor for Molecular and Translational Cardiology
Academic Career
- 1991 – 1998
Study of Medicine (Medical Colleges of the University of
Heidelberg and University of Lübeck)
- 1998 – 1999
Medical Internship, University Hospital Lübeck
- 1999
Full license to practice medicine (Approbation)
- 1999 – 2002
Resident, Department of Cardiology, Angiology and
Pulmonology, University Hospital Lübeck
- 2002
Medical doctorate degree/thesis defense (summa cum laude)
- 2002 – 2006
Resident, Department of Cardiology, Angiology and
Pulmonology, University Hospital Heidelberg- 2003 – 2004
Post-doctorate training, Center for Translational Medicine,
Thomas Jefferson University, Philadelphia, USA
- 2006 – 2010
Assistant Professor of Medicine and faculty member and,
Medical College and Department of Medicine, Thomas
Jefferson University Hospital, Philadelphia, USA
- 2009
Board certification
- seit 2010
W3-Professor for Molecular and Translational Cardiology, Medical College and Heidelberg University Hospital, Heidelberg Germany
Adjunct Associate Professor of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, USA
Bioindustrial Career
- 2013 – 2014
Co-founder and Chief Executive Officer of the Biotech Startup
InoCard GmbH- 2014 – 2017
Managing Director of uniQure GmbH Germany (successor to InoCard GmbH and German affiliation of uniQure NV, Amsterdam, Netherlands)
- 2015 – 2017
Member of the uniQure NV leadership team and Senior Vice
President Cardiovascular Therapeutic Area
- seit 2019
Co-founder of the Biotech Startup AaviGen GmbH
Awards/Honors
- 2001
German Society of Cardiology (DGK), of the Oskar Lapp
Foundation Science Award- 2001
Council on Basic Cardiovascular Sciences (BCVS) of the American Heart Association (AHA), Trainee Award
- 2002
Council on Basic Cardiovascular Sciences (BCVS) of the American Heart Association (AHA), Early Carrer Development Award
- 2004
Young Investigator Award of the German Society for Internal Medicine (DGIM)
- 2004
Wilhelm P. Winterstein Science Award of the German Heart
- 2004
Foundation (Deutsche Herzstiftung) Basic Science Award of the German Society for the Prevention and Rehabilitation of Cardiovascular Diseases (DGPR)
- 2004
Council on Basic Cardiovascular Sciences (BCVS) of the American Heart Association (AHA), Louis N. and Arnold M. Katz Price Finalist
- 2007
W.W. Smith Charitable Trust stipend award
- 2009
Innovation Award of BioRegion Germany Association
- 2010
ADUMED Science Award, ADUMED Foundation
- 2013
Investors’ Choice Award of the Health Axis Europe/BioRN
Excellence cluster competition- 2015
German Society of Cardiology (DGK), Albert-Fränkel Award
Patents (approved)
- Cardiac power failure treatment (WO2000/02453)
- Therapeutic Window S100A1 (PCT/EP13/186913)
- Muscle function enhancing peptide (PCT/EP10/002343)
- Short peptides for enhancing muscle function (PCT/EP13/880705)
- Tissue specific gene therapy treatment (WO2008/054713)